Phase 2 Study of Ketamine-Induced phBOLD in Healthy Volunteers
A study is underway to evaluate the effects of ketamine on brain activity using pharmacoBOLD imaging in healthy volunteers.
Phase II
Neurology / Depression
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
This Phase 2 study on ketamine's effects on brain activity could significantly advance understanding of glutamatergic mechanisms in depression. Insights gained may lead to innovative therapeutic strategies, impacting future treatment paradigms in neurology.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor outcomes related to brain activity changes and any subsequent publications on efficacy and safety.
Related companies & assets
Assets
Sources & Humanexa intelligence
Related Humanexa pages
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.